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INTRODUCTION
Cataract is the most common cause of treatable blindness world-
wide. Therefore, research related to the etiologic factors of catarac-
togenesis is always popular. Some well-known systemic conditions 
such as diabetes mellitus (DM) and systemic steroid intake promote 
cataract formation(1-4). Although it is controversial, some reports have 
shown the protective effect of estrogen against cataractogenesis(5,6). 
Therefore, the decrease in estrogen level with the onset of menopause 
may increase the risk of cataract in women(5,6).
Oxidative damage is a major cause of cataract formation(7). Accu-
mulation of oxidized lens components and decreased capacity of 
repair mechanisms promote cataractogenesis in several conditions 
such as aging and DM(8,9). In oxidative stress analysis, both the oxidant 
status and antioxidant capacity are important. Therefore, we used a 
practical, reliable, and effective method of oxidative stress analysis 
that measures total oxidant status (TOS) and total antioxidant capa-
city (TAC) in the lens(10,11).
We hypothesized that lenticular oxidative stress analysis may pro-
vide objective data on the cataractogenic effect of some systemic 
conditions. In this study, we aimed to compare the severity of len-
ABSTRACT
Purpose: To evaluate lenticular oxidative stress in rat menopausal models.
Methods: Forty Wistar female albino rats were included in this study. A total of 
thirty rats underwent oophorectomy to generate a menopausal model. Ten rats that 
did not undergo oophorectomy formed the control group (Group 1). From the rats 
that underwent oophorectomy, 10 formed the menopause control group (Group 
2), 10 were administered a daily injection of methylprednisolone until the end of 
the study (Group 3), and the remaining 10 rats were administered intraperitoneal 
streptozocin to induce diabetes mellitus (Group 4). Total oxidant status (TOS), total 
antioxidant capacity (TAC), and oxidative stress index (OSI) measurements of the 
crystalline lenses were analyzed. 
Results: The mean OSI was the lowest in group 1 and highest in group 4. Ne-
vertheless, the difference between the groups was not statistically significant in 
terms of OSI (p>0.05). The mean TOS values were similar between the groups 
(p>0.05), whereas the mean TAC of group 1 was significantly higher than that of 
the other groups (p<0.001). 
Conclusions: Our results indicate that menopause may not promote cataract 
formation.
Keywords: Menopause; Cataract; Oxidative stress; Lens, crystalline
RESUMO
Objetivo: Avaliar o estresse oxidativo lenticular em modelos de ratas na menopausa. 
Métodos: Quarenta ratos albinos femininos tipo Wistar foram incluídos neste estudo. 
Trinta ratas foram submetidas à ooforectomia para gerar o modelo de menopausa 
e 10 ratas formaram o grupo controle (Grupo 1). Dentre as ratas ooforectomizadas, 
10 formaram o grupo controle menopausa (Grupo 2), 10 ratas receberam injeção 
diária de metilprednisolona até ao final do estudo (Grupo 3) e 10 ratas receberam 
es treptozotocina por via intraperitoneal para induzir diabetes mellitus (Grupo 4). O 
estado oxidante total (TOS), a capacidade total antioxidante (TAC) e as medições do 
índice de estresse oxidativo (OSI) dos cristalinos foram analisados. 
Resultados: A média de OSI foi menor no grupo 1 e maior no grupo 4. Todavia, a 
diferença entre os grupos não foi estatisticamente significativa (p>0,05). Os valores 
médios TOS foram semelhantes entre os grupos (p>0,05), enquanto a média de TAC 
grupo 1 foi mais elevada do que nos outros grupos (p<0,001). 
Conclusões: Nossos resultados indicam que a menopausa podem não promover a 
formação de catarata.
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ticular oxidative stress generated by diabetes, systemic steroid use, 
and menopause in animal models. To the best of our knowledge, 
this study is the first in the literature to study the effects of systemic 
conditions on cataractogenesis using rat models.
METHODS
Forty mature (4-month-old) Wistar female albino rats with an 
average weight of 250 g were used in this study. The study adhered to 
the tenets of the Association for Research in Vision and Ophthalmo-
logy statement for the use of animals in research. The study protocol 
was approved by the Animal Care and Use Committee of Pamukkale 
University, Turkey.
Study groupS
The rats were obtained from the Experimental Research Unit 
of our university. The animals were housed in groups of four to five 
rats in stainless steel cages under standard conditions (24 ± 2°C and 
50 ± 5% humidity) with a 12-h light-dark cycle. The rats were fed 
ad libitum with standard rat chow and tap water. The experiments 
were performed between 9:00 and 12:00 AM.
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Thirty rats underwent oophorectomy to induce menopausal 
status. Oophorectomy was performed under sterile conditions via a 
midline incision (Figure 1) after anesthetization using intraperitoneal 
injection of ketamine hydrochloride (90 mg/kg; Ketalar, Pfizer, Espoo, 
Finland) and xylazine (10 mg/kg; Kepro xylazine 201, Biopharm, Istan-
bul, Turkey). The incisions were closed with 3.0 polyglactin sutures. 
The remaining 10 rats formed the control group (Group 1). Ten of the 
30 rats that underwent oophorectomy constituted the menopause 
control group (Group 2). Beginning 1 week after the operation, me-
thylprednisolone (1 mg/kg) was injected daily until the end of the 
study to mimic steroid treatment for rheumatologic diseases in 10 
rats (Group 3). Group 4 consisted of rats that received intraperitoneal 
administration of streptozocin (50 mg/kg) to induce DM 1 week after 
the oophorectomy. Blood glucose level was checked 3 days after 
streptozocin administration, and values >250 mg/dL were conside-
red as positive for DM. 
Three rats in the menopause-diabetes group died during follow-up. 
All of the rats were deeply anesthetized with intraperitoneal keta-
mine (90 mg/kg) and xylazine (10 mg/kg) and sacrificed by cervical 
dislocation 11 weeks after the oophorectomy. The crystalline lenses 
were gently extracted through a large limbal corneal incision while 
protecting the whole lens structure. Both lenses of the right and left 
eyes were analyzed. The tissues were stored at -80°C for subsequent 
analysis. The values of TOS, TAC, and oxidative stress index (OSI) were 
measured in the lenses of the four different animal models and then 
compared among the groups. The investigators who measured the 
values were blinded to the composition of the groups.
The lens samples were homogenized with cold lysis tamponade 
(1 M Tris, 1% sodium dodecyl sulfate, protease inhibitor cocktail; 
pH 7.4; Complete; Roche Diagnostics, Basel, Switzerland), and the 
supernatants were obtained after centrifuging at 4°C and 15,000 × g 
for 10 min. The protein levels of the supernatants were determined 
with the Lowry method(12).
MeaSureMentS of lenS toS and taC 
TOS of the lens was measured with an automated colorimetric 
measurement method that was improved by Erel(10). In this method, 
the ferrous ion–o-dianisidine complex is oxidized to ferric ion by the 
oxidants present in the sample. The glycerol molecules, which are 
plentiful in the reaction medium, intensify the oxidation reaction. The 
ferric ion forms a colored complex with xylenol orange in an acidic 
medium. The color intensity can be measured spectrophotometri-
cally and is related to the total amount of oxidant molecules (lipids 
and proteins) present in the sample. The assay is calibrated using 
hydrogen peroxide, and the results are expressed in µmol/L.
TAC of the lens was measured with an automated colorimetric 
measurement method for TAC improved by Erel(11). In this method, 
the most powerful biological radical-the hydroxyl radical-is produced 
via the Fenton reaction, and it reacts with the colorless substrate 
o-dianisidine to produce the dianisyl radical, which has a bright 
yellowish brown color. After the addition of the lens homogenate, 
oxidative reactions are suppressed by the antioxidant components 
of the sample, thereby preventing color change and producing 
an effectual measure of the plasma TAC level. The assay results are 
indicated in mmol/L. The ratio of TOS to TAC is referred to as OSI. 
To perform this calculation, the result unit of measurement of 
TAC-mmol Trolox equivalent/L-was changed to µmol Trolox equi-
valent/L. OSI is calculated according to the following formula: 
OSI (arbitrary unit) = TOS (µmol/L)/[TAC (µmol Trolox equivalent/L)/100](13)
The lens morphology and cataract scores were assessed following 
the removal of the crystalline lenses. We used a basic cataract scoring 
system in which lenticular opacity is recorded as (+) and a clear lens 
is recorded as (−). We did not have the opportunity to take photo-
graphic images of the eyes. Gross examination and light microscopy 
were used to detect lenticular opacity. 
StatiStiCal analySiS
All analyses were conducted using the computerized SPSS 21.0 
program (Statistical Package for Social Sciences; IBM Corp., Armonk, 
NY, USA). p values of <0.05 were considered statistically significant. 
The results are expressed as the means ± standard deviation. Statistical 
analysis among the groups was performed using one-way analysis 
of variance followed by the least significant difference post hoc test. 
p values from Levene’s test were >0.05 for all studied parameters.
RESULTS
The mean TOS, TAC, and OSI values of the groups are summarized 
in table 1. The mean TOS was the highest in group 2 and lowest in 
group 3 as shown in figure 2 A; however, the difference among the 
groups was not statistically significant (p=0.74). TAC was the highest 
in group 1 and lowest in group 3 as shown in figure 2 B; the difference 
among the groups was statistically significant (p<0.001). 
The mean OSI was the lowest in group 1 and highest in group 4 
as shown in figure 2 C. OSI of group 4 was 60% higher than that of 
group 1, but the difference among the groups was not statistically 
significant (p=0.56). We did not observe morphological differences 
in the crystalline lenses between the groups (p>0.05), but lenticular 
opacity was more frequent in groups 3 and 4 (p<0.05).
Figure 1. Procedure of oophorectomy to induce menopause in a rat 
model under general anesthesia.
Table 1. The mean TOS, TAC, and OSI values of the four study groups 
are shown
Group 1 Group 2 Group 3 Group 4 p
TOS 0.22 ± 0.14 0.23 ± 0.16 0.19 ± 0.19 0.22 ± 0.15 <0.740
TAC 0.25 ± 0.06 0.17 ± 0.05 0.13 ± 0.04 0.15 ± 0.03 <0.001
OSI 0.09 ± 0.06 0.13 ± 0.07 0.14 ± 0.09 0.15 ± 0.09 <0.560
(TOS= total oxidative status; TAC= total antioxidant capacity, OSI= oxidative stress index)
Group 1= normal rats without oophorectomy (non-menopausal); Group 2= rats underwent 
oophorectomy only (menopause control); Group 3= rats underwent oophorectomy and 
received steroids; Group 4= rats underwent oophorectomy and had diabetes mellitus.
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DISCUSSION
Our results showed that menopause may not be associated 
with cataract progression. The lenticular OSI in menopause-diabetes 
group is superior than that in menopause-steroid group. In general, 
oxidative stress is higher in males, and the higher level of estrogen 
in females protects them against aging(14). Because cataract may be 
caused by the aging of the crystalline lens in most instances, it should 
be expected that the removal of estrogen increases lenticular OSI.
Several population-based studies have revealed that an increased 
rate of cataract surgery is associated with menopause(15,16). Estrogen 
may exert a protective effect against the oxidative stress that is im-
portant in cataractogenesis(5). In the present study, TOS increased and 
TAC decreased in the crystalline lens of rats following menopause 
induction. Nevertheless, our results suggested that estrogen removal 
does not promote cataract formation.
There is a strong association between cataract formation and sys-
temic corticosteroid treatment(17). Steroids may bind to lens proteins, 
resulting in the destabilization of the protein structure and the for-
mation of cataract(18). Systemic methylprednisolone administration 
has been shown to induce rat lens opacity(19). The protective effect 
of methylprednisolone against oxidative injury has been found in 
several disease types(20-24). However, no studies in the literature have 
related the impact of systemic methylprednisolone to the oxidative 
stress of crystalline lenses. In the present study, both TOS and TAC 
decreased in the lens of menopause-induced rats following systemic 
administration of methylprednisolone when compared with those of 
the controls. As OSI is the ratio of TOS to TAC, it is a better parameter 
for comparison than either TOS or TAC alone. Although OSI was found 
to be similar in the menopause only and menopause-steroid groups, 
lenticular opacity was more frequent in the menopause-steroid group. 
DM increases oxidative stress in tissues, which in turn plays a role 
in the pathogenesis of various diabetic complications such as cata-
ract(25,26). Reactive oxygen species promote a series of cellular respon-
ses that result in abnormal cellular functions. The polyol pathway was 
found to be an important contributor to oxidative stress in the lenses 
of diabetic mice(25). Inhibition of aldose reductase, an important en-
zyme in the polyol pathway, was shown to be effective at preventing 
cataract formation(27). In the present study, both TOS and TAC were 
lower in the menopause-diabetes group than in the menopause only 
group. However, OSI was the highest in the menopause-diabetes 
group, which could be interpreted as the most cataractogenically 
influenced.
Lenticular oxidative stress accumulation such as that seen in me-
nopause does not necessarily mean cataract formation. It is impor-
tant to find the association between OSI and lens opacity. Although 
our study lacks detailed lens photographs and slit-lamp analysis, we 
assessed cataract formation by light microscopy and inspection 
following lens extraction. We analyzed the lens in vitro rather than in 
vivo; nevertheless, we speculate that high OSI index may be associa-
ted with lenticular opacity. 
Our study has some limitations. First, it would be better if we had 
additional study groups such as DM-only and steroid-only groups. 
Second, the effect of estrogen replacement was not investigated. 
Lastly, photographic analysis of the lens could be added for detailed 
cataract grading. Further, the model used could be referred to as 
oophorectomized rats instead of menopausal rats.
In conclusion, the outcomes of this study suggest that estrogen is 
not a protective factor against lenticular oxidative stress. In addition, 
methylprednisolone does not provide a protective effect against 
oxidative stress in crystalline lenses. The OSI was the highest in the 
menopause-diabetes model.
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